Illumina (ILMN) returns
TrendArc score 50 of 100 · Health 8.6 · Momentum 2.8 · Moat 4.6 · scored Nov 17, 2026 · How the score works
Illumina returns over 10 years
$1,000 invested in Illumina ten years ago was worth $1,553 at the close on November 17, 2026, with dividends reinvested: an average return of 4.5% a year. The same $1,000 in the S&P 500 (SPY) became $3,919.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -22.8% | — | $771.73 | -4.0% |
| 3 months | +4.9% | — | $1,049 | -5.0% |
| Year to date | +54.5% | — | $1,545 | +8.2% |
| 1 year | +68.7% | — | $1,687 | +11.2% |
| 3 years | +120.8% | +30.2% | $2,208 | +68.5% |
| 5 years | -44.8% | -11.2% | $551.55 | +67.3% |
| 10 years | +55.3% | +4.5% | $1,553 | +291.9% |
Illumina return by calendar year
| Year | ILMN | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +54.5% | +8.2% | +46.2% |
| 2025 | -1.8% | +17.7% | -19.6% |
| 2024 | -1.3% | +24.9% | -26.2% |
| 2023 | -31.1% | +26.2% | -57.3% |
| 2022 | -46.9% | -18.2% | -28.7% |
| 2021 | +2.8% | +28.7% | -25.9% |
| 2020 | +11.5% | +18.4% | -6.8% |
| 2019 | +10.6% | +31.2% | -20.6% |
| 2018 | +37.3% | -4.6% | +41.8% |
| 2017 | +70.6% | +21.7% | +48.9% |
| 2016 | -33.3% | +12.0% | -45.3% |
Illumina returns against its peers
| Company | 1 year | 3 years | 5 years | 10 years |
|---|---|---|---|---|
| IlluminaILMN | +68.7% | +120.8% | -44.8% | +55.3% |
| Mettler ToledoMTD | +23.3% | +63.3% | +11.7% | +309.3% |
| IQVIAIQV | +19.2% | +25.8% | -2.6% | +224.1% |
| WatersWAT | +19.0% | +71.8% | +31.0% | +223.9% |
| Agilent TechnologiesA | +20.1% | +55.6% | +10.5% | +304.9% |
| Charles River LaboratoriesCRL | +104.1% | +75.7% | -15.5% | +350.6% |
| Bio-TechneTECH | +24.6% | +20.9% | -39.7% | +192.0% |
| Peer median | +21.7% | +59.5% | +3.9% | +264.5% |
| S&P 500 (SPY) | +11.2% | +68.5% | +67.3% | +291.9% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: ILMN financials · ILMN valuation
No forecast, no recommendation. This page describes Illumina from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Nov 17, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.
The TrendArc score, from 0 to 100, combines three pillars measured from published data, Health (business quality over the last twelve months), Momentum (the price against its moving averages, its 52-week high and the market) and Moat (durability over five years), with the share price's long-run trend. It describes the company as it stands today. It is not a forecast or a recommendation.